Find uplifting stories about heroes, innovations, and solutions
12 results for "vaccine breakthrough"
For the first time in decades, a vaccine to prevent Lyme disease is showing real promise. Pfizer's new vaccine candidate demonstrated over 75% effectiveness in a major clinical trial, offering hope to millions who spend time outdoors.
Scientists in South Africa are leading a breakthrough tuberculosis vaccine trial that could protect adolescents and adults for the first time in over a century. The M72 vaccine, combined with faster tests and shorter treatments, marks a turning point against the world's deadliest infectious disease.
After decades without a Lyme vaccine, Pfizer's new candidate proved more than 70% effective at preventing the disease in a major clinical trial. The breakthrough brings hope to millions who face the threat of this debilitating illness every time they step outdoors.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
A new vaccine could soon protect people from Lyme disease for the first time in over 20 years. Pfizer and Valneva's candidate showed over 70% effectiveness in preventing the tick-borne illness that affects hundreds of thousands annually.
After 20 years of work, University of Guelph scientists have successfully tested the world's first human vaccine against campylobacter jejuni, the number one bacterial cause of diarrhea worldwide. The breakthrough could protect travelers, children in developing nations, and millions who suffer from this preventable illness each year.
A groundbreaking vaccine against a bacteria that sickens millions worldwide just passed human safety trials with flying colors. The sugar-based shot could prevent a leading cause of severe diarrhea and save lives across the globe.
Scientists at Stanford developed a nasal spray vaccine that primes your lungs to fight nearly any respiratory threat, from viruses to bacteria to allergens. Human trials could begin soon, potentially transforming how we protect ourselves during flu season and future pandemics.
Scientists at Stanford Medicine have developed a revolutionary nasal spray vaccine that protects against multiple respiratory threats at once. In mice, the single spray defended against COVID-19, flu, bacterial pneumonia, and even allergies for months.
Scientists at Stanford Medicine have developed a breakthrough nasal spray vaccine that protects against multiple respiratory threats at once, from COVID-19 and flu to bacterial infections and even allergies. In mice, the experimental vaccine provided months of broad protection by supercharging the lungs' natural defenses instead of targeting specific pathogens.
Australian researchers have developed a promising vaccine against chikungunya, a mosquito-borne virus that leaves up to 60% of patients suffering chronic joint pain for months or years. The innovative approach uses engineered bacteria to create virus-like particles that train the immune system without causing illness.
Scientists in Japan are launching the first human trial of a Nipah vaccine in April, targeting a virus that kills up to 75% of those infected. With no current treatment available, this breakthrough could save thousands of lives in regions where outbreaks occur.